Skip to content

Regencell Bioscience Holdings Limited

RGC

CIK 0001829667

← back to feed
Revenue (TTM)
—
FY Jun 2025
Net Income (TTM)
−$3.58M
+16.7% YoY FY Jun 2025
EPS Diluted (TTM)
−$0.72
+17.2% YoY FY Jun 2025
Gross Margin
—
FY Jun 2025
Operating Margin
—
FY Jun 2025
Net Margin
—
FY Jun 2025
Free Cash Flow (TTM)
−$3.27M
FY Jun 2025
Cash
$6.42M
FY Jun 2025
Total Debt
$3M
FY Jun 2025
Shares Outstanding
494.49M sh
FY Jun 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings